Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
26877 | 243 | 21.5 | 47% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
522 | 3 | MAGNESIUM-BULLETIN//MAGNESIUM RESEARCH//MAGNESIUM | 20526 |
878 | 2 | NEBIVOLOL//CARVEDILOL//BETA BLOCKERS | 11463 |
26877 | 1 | DOXAZOSIN MESYLATE//SELECTIVE ALPHA1 BLOCKERS//BASIC DRUG ANALYSIS | 243 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DOXAZOSIN MESYLATE | authKW | 410481 | 3% | 47% | 7 |
2 | SELECTIVE ALPHA1 BLOCKERS | authKW | 376980 | 1% | 100% | 3 |
3 | BASIC DRUG ANALYSIS | authKW | 251320 | 1% | 100% | 2 |
4 | DETERMINATION OF DOXAZOSIN | authKW | 251320 | 1% | 100% | 2 |
5 | ZORBAX RX C8 COLUMN | authKW | 251320 | 1% | 100% | 2 |
6 | PRAZOSIN HYDROCHLORIDE | authKW | 223391 | 2% | 44% | 4 |
7 | TERAZOSIN | authKW | 203379 | 6% | 11% | 15 |
8 | PHARMA ANAL | address | 167545 | 1% | 67% | 2 |
9 | POLYTHIAZIDE | authKW | 167545 | 1% | 67% | 2 |
10 | 4 AMINO 6 CHLORO 1 3 BENZENEDISULFONAMIDE | authKW | 125660 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1802 | 50% | 0% | 122 |
2 | Chemistry, Analytical | 1668 | 36% | 0% | 87 |
3 | Biochemical Research Methods | 274 | 12% | 0% | 29 |
4 | Cardiac & Cardiovascular System | 144 | 11% | 0% | 26 |
5 | Chemistry, Medicinal | 125 | 7% | 0% | 18 |
6 | Medicine, General & Internal | 57 | 9% | 0% | 21 |
7 | Chemistry, Multidisciplinary | 43 | 12% | 0% | 28 |
8 | Electrochemistry | 11 | 2% | 0% | 6 |
9 | Spectroscopy | 10 | 2% | 0% | 6 |
10 | Toxicology | 4 | 2% | 0% | 5 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMA ANAL | 167545 | 1% | 67% | 2 |
2 | AREA BROMATOL ENSAYO VALORAC MED | 125660 | 0% | 100% | 1 |
3 | MINITURE RUMENT | 125660 | 0% | 100% | 1 |
4 | TI CORE INNOVAT SQ | 125660 | 0% | 100% | 1 |
5 | BIOEQUIVALENCE TEST | 80777 | 1% | 21% | 3 |
6 | ANALYT CHEMDISCOVERY | 62829 | 0% | 50% | 1 |
7 | FARM QUIM ANAL | 62829 | 0% | 50% | 1 |
8 | INTERNAL MED CLIN UNIT | 62829 | 0% | 50% | 1 |
9 | NODCAR | 62829 | 0% | 50% | 1 |
10 | UV GRP | 62829 | 0% | 50% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 8923 | 10% | 0% | 24 |
2 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 4561 | 8% | 0% | 20 |
3 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 2239 | 6% | 0% | 14 |
4 | REVIEWS IN ANALYTICAL CHEMISTRY | 1717 | 1% | 1% | 2 |
5 | REVISTA BRASILEIRA DE MEDICINA | 1280 | 0% | 1% | 1 |
6 | JOURNAL OF LIQUID CHROMATOGRAPHY | 1270 | 2% | 0% | 6 |
7 | PHARMAZIE | 1133 | 4% | 0% | 9 |
8 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1127 | 3% | 0% | 8 |
9 | JOURNAL OF CHROMATOGRAPHIC SCIENCE | 1091 | 2% | 0% | 6 |
10 | JOURNAL OF CHROMATOGRAPHY | 971 | 5% | 0% | 12 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DOXAZOSIN MESYLATE | 410481 | 3% | 47% | 7 | Search DOXAZOSIN+MESYLATE | Search DOXAZOSIN+MESYLATE |
2 | SELECTIVE ALPHA1 BLOCKERS | 376980 | 1% | 100% | 3 | Search SELECTIVE+ALPHA1+BLOCKERS | Search SELECTIVE+ALPHA1+BLOCKERS |
3 | BASIC DRUG ANALYSIS | 251320 | 1% | 100% | 2 | Search BASIC+DRUG+ANALYSIS | Search BASIC+DRUG+ANALYSIS |
4 | DETERMINATION OF DOXAZOSIN | 251320 | 1% | 100% | 2 | Search DETERMINATION+OF+DOXAZOSIN | Search DETERMINATION+OF+DOXAZOSIN |
5 | ZORBAX RX C8 COLUMN | 251320 | 1% | 100% | 2 | Search ZORBAX+RX+C8+COLUMN | Search ZORBAX+RX+C8+COLUMN |
6 | PRAZOSIN HYDROCHLORIDE | 223391 | 2% | 44% | 4 | Search PRAZOSIN+HYDROCHLORIDE | Search PRAZOSIN+HYDROCHLORIDE |
7 | TERAZOSIN | 203379 | 6% | 11% | 15 | Search TERAZOSIN | Search TERAZOSIN |
8 | POLYTHIAZIDE | 167545 | 1% | 67% | 2 | Search POLYTHIAZIDE | Search POLYTHIAZIDE |
9 | 4 AMINO 6 CHLORO 1 3 BENZENEDISULFONAMIDE | 125660 | 0% | 100% | 1 | Search 4+AMINO+6+CHLORO+1+3+BENZENEDISULFONAMIDE | Search 4+AMINO+6+CHLORO+1+3+BENZENEDISULFONAMIDE |
10 | ALFUZOSINE HCI | 125660 | 0% | 100% | 1 | Search ALFUZOSINE+HCI | Search ALFUZOSINE+HCI |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BAKSHI, M , OJHA, T , SINGH, S , (2004) VALIDATED SPECIFIC HPLC METHODS FOR DETERMINATION OF PRAZOSIN, TERAZOSIN AND DOXAZOSIN IN THE PRESENCE OF DEGRADATION PRODUCTS FORMED UNDER ICH-RECOMMENDED STRESS CONDITIONS.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 34. ISSUE 1. P. 19-26 | 31 | 89% | 27 |
2 | SHRIVASTAVA, A , GUPTA, VB , (2012) VALIDATED HPLC AND HPTLC METHODS FOR SIMULTANEOUS DETERMINATION OF SOME ALPHA(1)-ADRENORECEPTOR BLOCKERS.LATIN AMERICAN JOURNAL OF PHARMACY. VOL. 31. ISSUE 2. P. 279-286 | 22 | 61% | 1 |
3 | EL SHEIKH, R , ESMAIL, NS , GOUDA, AA , BASSET, WA , (2012) EXTRACTIVE SPECTROPHOTOMETRIC DETERMINATION OF SOME ALPHA-ADRENERGIC-ANTAGONISTS IN PURE FORMS AND IN PHARMACEUTICAL FORMULATIONS.CHEMICAL INDUSTRY & CHEMICAL ENGINEERING QUARTERLY. VOL. 18. ISSUE 2. P. 179-191 | 16 | 76% | 0 |
4 | HOLMES, B , SORKIN, EM , (1986) INDORAMIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN HYPERTENSION AND RELATED VASCULAR, CARDIOVASCULAR AND AIRWAY DISEASES.DRUGS. VOL. 31. ISSUE 6. P. 467-499 | 35 | 88% | 17 |
5 | AYDODMUP, Z , BARLA, A , (2009) SPECTROPHOTOMETRIC DETERMINATION OF DOXAZOSIN MESYLATE IN TABLETS BY ION-PAIR AND CHARGE-TRANSFER COMPLEXATION REACTIONS.JOURNAL OF AOAC INTERNATIONAL. VOL. 92. ISSUE 1. P. 131-137 | 17 | 74% | 6 |
6 | AHMED, S , MOHAMED, NA , EL ZOHNY, SA , (2015) A SENSITIVE AND RELIABLE METHOD FOR THERAPEUTIC MONITORING OF ALPHA(1)-BLOCKERS IN RABBIT PLASMA BY ION-PAIR CHROMATOGRAPHY WITH ENHANCED FLUORESCENCE DETECTION.MICROCHEMICAL JOURNAL. VOL. 122. ISSUE . P. 214 -222 | 21 | 50% | 0 |
7 | MOHAMED, NA , AHMED, S , EL ZOHNY, SA , (2013) RAPID AND SENSITIVE ONLINE DETERMINATION OF SOME SELECTIVE ALPHA(1)-BLOCKERS BY FLOW INJECTION ANALYSIS WITH MICELLE-ENHANCED FLUORESCENCE DETECTION.JOURNAL OF FLUORESCENCE. VOL. 23. ISSUE 6. P. 1301-1311 | 16 | 62% | 1 |
8 | VILLA, AF , HONG, HT , LEE, HM , CHATAIGNER, D , GARNIER, R , (2012) ACUTE INDORAMIN POISONING: A REVIEW OF 55 CASES REPORTED TO THE PARIS POISON CENTRE FROM 1986 TO 2010.THERAPIE. VOL. 67. ISSUE 6. P. 523-527 | 13 | 76% | 0 |
9 | RAO, RN , NAGARAJU, D , DAS, AK , JENA, N , (2007) SEPARATION, CHARACTERIZATION, AND QUANTITATION OF PROCESS-RELATED SUBSTANCES OF THE ANTI-HYPERTENSIVE DRUG DOXAZOSIN MESYLATE BY REVERSED-PHASE LC WITH PDA AND ESI-MS AS DETECTORS.JOURNAL OF CHROMATOGRAPHIC SCIENCE. VOL. 45. ISSUE 2. P. 63 -69 | 13 | 81% | 2 |
10 | ZIZKOVSKY, V , KUCERA, R , KLIMES, J , HOLASKOVA, P , DOHNAL, J , (2009) RP-ZRO2 STATIONARY PHASE AS AN ALTERNATIVE TO SEPARATE OF DOXAZOSIN IMPURITIES.CHROMATOGRAPHIA. VOL. 70. ISSUE 1-2. P. 185 -189 | 17 | 59% | 1 |
Classes with closest relation at Level 1 |